Affiliate to sell 24,375 shares at CGEN (CGEN) — proposed 03/26/2026

Rhea-AI Filing Summary

CGEN affiliate filed a notice to sell 24,375 ordinary shares. The filing lists two option-originated lots: 22,375 shares from an 11/09/2022 grant and 2,000 shares from an 08/03/2023 grant, with the proposed sale date of 03/26/2026. The filing lists an aggregate amount of $50,212.50 and shows 94,553,191 shares outstanding as of 03/26/2026 as context.

Insights

Securities Compliance Analyst

Notice of proposed affiliate sale of 24,375 ordinary shares under employee option grants.

The notice lists two option lots totaling 24,375 shares with a proposed sale date of 03/26/2026 and an aggregate value reported as $50,212.50. This is a regulatory notice under resale rules and does not itself record a completed market sale.

Cash‑flow treatment and buyer details are not provided in the excerpt; subsequent Form 4 or transaction reports would show completed dispositions if executed.

Equity Capital Markets Specialist

Scale is small relative to the reported outstanding share count.

The filing shows 24,375 shares against 94,553,191 shares outstanding as of 03/26/2026, indicating a negligible overhang on supply. The listed aggregate value is $50,212.50, implying a low notional size for market impact.

Investor impact depends on whether the options are exercised and sold; timing and execution method are not detailed in the excerpt.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary Shares	Oppenheimer & Co. Inc 85 Broad St. New York NY 10004	24375	50212.50	94553191	03/26/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary shares	11/09/2022	Employee Stock Options plan	The issuer			22375	03/26/2026	Cash - Upon Exercise
Ordinary shares	08/03/2023	Employee Stock Options plan	The issuer			2000	03/26/2026	Cash - Upon Exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does CGEN's Form 144 disclose?

It discloses a proposed sale of 24,375 ordinary shares by an affiliate, with a proposed sale date of 03/26/2026. The filing lists two option-derived lots of 22,375 and 2,000 shares and an aggregate value of $50,212.50.

Does the Form 144 show proceeds to the issuer for CGEN?

The filing lists an aggregate amount of $50,212.50 tied to the proposed sale. It does not state any proceeds treatment for the issuer or whether proceeds flow to the selling affiliate.

How large is the proposed sale versus CGEN's outstanding shares?

The filing shows 24,375 shares proposed for sale and reports 94,553,191 shares outstanding as of 03/26/2026. The proposed lot is small relative to the stated outstanding share count.

Are the shares in the filing from option exercises?

Yes. The filing lists two items from the Employee Stock Options plan: one grant dated 11/09/2022 for 22,375 shares and one dated 08/03/2023 for 2,000 shares, described as cash‑upon‑exercise originations.

Does this filing mean the shares have already been sold?

No. Form 144 is a notice of a proposed resale; the excerpt shows a proposed sale date of 03/26/2026. Execution and actual sale details would appear in separate transaction reports if completed.